![Martin Cross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Cross
Directeur/Membre du Conseil chez
Nhmrc National Institute of Dementia Research
Profil
Martin Cross currently works at Nhmrc National Institute of Dementia Research, as Non-Executive Director.
Dr. Cross also formerly worked at Generic Medicines Industry Association Pty Ltd., as Chairman from 2010 to 2013, Medicines Australia, as Chairman from 2013 to 2015, Anagenics Ltd., as Non-Executive Director from 2017 to 2023, OncoSil Medical Ltd., as Independent Non-Executive Director from 2017 to 2022, Alphapharm Pty Ltd., as Managing Director from 2010 to 2013, Novartis Australia Pty Ltd., as Managing Director & Head-Country from 2003 to 2008, Novartis New Zealand Ltd., as Managing Director & Head-Country from 2003 to 2008, and Novartis AG, as Head-Global Marketing from 2001 to 2003.
Dr. Cross received his undergraduate degree and doctorate degree from the University of Aberdeen.
Postes actifs de Martin Cross
| Sociétés | Poste | Début |
|---|---|---|
Nhmrc National Institute of Dementia Research | Directeur/Membre du Conseil | - |
Anciens postes connus de Martin Cross
| Sociétés | Poste | Fin |
|---|---|---|
| ANAGENICS LIMITED | Directeur/Membre du Conseil | 27/11/2023 |
| ONCOSIL MEDICAL LIMITED | Directeur/Membre du Conseil | 24/10/2022 |
Medicines Australia
 Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Président | 01/01/2015 |
Alphapharm Pty Ltd.
 Alphapharm Pty Ltd. Pharmaceuticals: GenericHealth Technology Develops and produces generic medicines | Directeur Général | 01/10/2013 |
Generic Medicines Industry Association Pty Ltd.
 Generic Medicines Industry Association Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as an association of pharmaceutical manufacturers | Président | 01/01/2013 |
Formation de Martin Cross
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Anagenics Ltd.
 Anagenics Ltd. Household/Personal CareConsumer Non-Durables Develops, manufactures and distributes hair care, therapeutic, prognostic and diagnostic products | Consumer Non-Durables |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Aberdeen
 University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoSil Medical Ltd.
 OncoSil Medical Ltd. Medical SpecialtiesHealth Technology Develops and commercializes neurology services including those for pancreatic cancer | Health Technology |
Alphapharm Pty Ltd.
Alphapharm Pty Ltd. Pharmaceuticals: GenericHealth Technology Develops and produces generic medicines | Health Technology |
Generic Medicines Industry Association Pty Ltd.
Generic Medicines Industry Association Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as an association of pharmaceutical manufacturers | Commercial Services |
Novartis Australia Pty Ltd.
 Novartis Australia Pty Ltd. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
Novartis New Zealand Ltd.
 Novartis New Zealand Ltd. Medical DistributorsDistribution Services Markets pharmaceutical products | Distribution Services |
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Health Technology |
Nhmrc National Institute of Dementia Research |
